Breaking News
December 10, 2018 - Some Brain Tumors May Respond to Immunotherapy, New Study Suggests
December 10, 2018 - Banning junk food ads to combat childhood obesity
December 10, 2018 - Skin Autofluorescence Predicts T2DM, Heart Disease, Mortality
December 10, 2018 - Largest autism sequencing study to date yields 102 genes associated with ASD
December 10, 2018 - Statins associated with low risk of side effects
December 10, 2018 - Study explores how schools address adolescent self-harming practices
December 10, 2018 - Pregnancy in adolescence linked to increased risks of complications in young mothers
December 10, 2018 - Risk Analysis publishes special issue on communicating about Zika virus
December 10, 2018 - Botox May Help Prevent Post-Op A-Fib
December 10, 2018 - African-American mothers rate boys higher for ADHD
December 10, 2018 - Graphic warning labels cancel out cigarettes’ appeal to young people
December 10, 2018 - Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
December 10, 2018 - Individual neurons located within the brain have implications for psychiatric diseases
December 10, 2018 - Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
December 10, 2018 - HPV type 16 or 18 associated with cervical cancer risk in young women
December 10, 2018 - Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities
December 10, 2018 - Combo therapy not needed if low RA disease activity achieved
December 10, 2018 - Novel therapeutic targets based on biology of aging show promise for Alzheimer’s disease
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Eating disorders now a top priority with Australian Government
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
December 8, 2018 - Scientists overturn odds to make Parkinson’s discovery
December 8, 2018 - Health benefits of producing marula vinegar
December 8, 2018 - Failure of critical cellular energy sensor responsible for CKD progression, study finds
December 8, 2018 - Ethnicity can be reliable indicator of gut microbiota diversity
December 8, 2018 - Safe Sleep for Baby | NIH News in Health
Single PSA Test Fails to Reduce Prostate Ca Deaths

Single PSA Test Fails to Reduce Prostate Ca Deaths

image_pdfDownload PDFimage_print

Action Points

  • One-time screening with a prostate-specific antigen (PSA) test failed to reduce prostate cancer deaths at 10 years, according to results of a randomized trial including over 400,000 British men in 573 primary care practices.
  • Recognize that screening for prostate cancer using PSA tests remains controversial, as the potential benefits of disease detection in its early stages can be outweighed by harms from overtreatment.

One-time screening with a prostate-specific antigen (PSA) test failed to reduce prostate cancer deaths at 10 years, despite an uptick in diagnoses of the disease, according to results of a randomized trial that included over 400,000 British men.

During the trial, 549 of 189,386 patients in the screening arm died from prostate cancer (0.30 per 1,000 person-years) compared with 647 of 219,439 patients in the control arm (0.31 per 1,000 person-years) for a rate ratio of 0.96 (P=0.50).

“The Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP) was designed to determine the effects of a low-intensity, single invitation PSA test,” wrote Richard M. Martin, PhD, of the University of Bristol, England, in JAMA. “Although longer-term follow-up is under way, the findings do not support single PSA testing for population-based screening.”

The trial included 419,582 men ages 50 to 69 screened at 573 primary care practices across the United Kingdom. Patients were recruited beginning in 2001, with follow-up concluding in 2016.

While no reduction in deaths due to prostate cancer were seen among screened patients, more cases of the disease were diagnosed in men receiving a PSA test (4.3%) compared with unscreened patients (3.6%). More tumors with a Gleason score of 6 or lower were identified in the screened group compared with the control group (1.7% versus 1.1%, respectively).

Localized disease (stage T1 or T2 cancer) was diagnosed at a more frequent rate in the screened group (2.6% versus 1.9% in the control group); in turn, fewer cases of advanced-stage cancer were diagnosed in this group (0.5% versus 0.6% in the control group).

Of the 549 men who died of prostate cancer in the screening group, only 188 had visited the clinic for PSA testing. Lethal cancer was diagnosed in 59 of these 188. Of the remaining 129 patients:

  • 68 were ineligible for prostate biopsy due to a PSA level less than 3.0 ng/mL,
  • 42 did not undergo PSA testing despite having attended the clinic,
  • 15 men had a PSA level 3.0 ng/mL or higher yet did not undergo a biopsy,
  • and 4 men had a benign biopsy.

In the all-cause mortality analysis, 25,459 died in the intervention group compared with 28,306 in the control group for a RR of 0.99 (P=0.49).

Screening for prostate cancer using PSA tests remains controversial, as the potential benefits of disease detection in its early stages can be outweighed by harms from overtreatment. In 2012, the U.S. Preventive Services Task Force (USPSTF) recommended against routine PSA screening for men of any age, but in 2017 adjusted this recommendation and now support an individualized approach to screening for men ages 55 to 69.

“It has been hypothesized that screening men in their early 50s may be more effective than at a later age,” the authors wrote. “However, we did not find statistical evidence to support this.”

In terms of adherence to screening, 75,707 patients (40%) of the 189,386 men assigned to the intervention arm attended the clinic for PSA testing; 67,313 of these men underwent PSA testing. High PSA levels — 3.0 ng/mL to 19.9 ng/mL — were detected in 6,857 patients and 5,850 underwent a biopsy.

In an editorial accompanying the article, Michael J. Barry, MD, of Harvard Medical School and Massachusetts General Hospital in Boston, wrote: “A key question is whether the findings from the CAP trial should swing the pendulum further in the direction of not offering screening PSA tests. Based on the CAP results, an offer of a single PSA screen in a population of men aged 50 to 69 years is ineffective, and given the higher risk of a prostate cancer diagnosis this approach engenders, likely does more harm than good.”

Barry, who is a member of the USPSTF, added that while further follow-up from CAP could potentially reveal benefit, based on the evidence so far “that eventuality seems unlikely.”

Martin and co-authors reported no conflicts of interest. Barry is chief science officer at Healthwise, and grants from the company have been awarded to Massachusetts General Hospital.

The CAP trial was funded by grants from Cancer Research U.K., and partial funding was provided by the U.K. Department of Health, National Institute of Health Research.

2018-06-03T00:00:00-0400

last updated

Tagged with:

About author

Related Articles